Hypereosinophilia with rash to dobutamine infusion; sulfite hypersensitivity diagnosed by in vitro stimulation assays
Author(s) -
Sung-Yoon Kang,
Ji-Won Lee,
Da-Eun Park,
Bo-ram Bae,
Hyun Seung Lee,
Byung-Keun Kim,
JuYoung Kim,
Kyung-Hwan Lim,
HeungWoo Park,
BonKwon Koo,
SangHeon Cho,
WooJung Song
Publication year - 2016
Publication title -
allergology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.49
H-Index - 58
eISSN - 1440-1592
pISSN - 1323-8930
DOI - 10.1016/j.alit.2016.01.008
Subject(s) - hypereosinophilia , medicine , stimulation , rash , dobutamine , in vitro , immunology , pharmacology , dermatology , chemistry , eosinophilia , biochemistry , hemodynamics
Dobutamine is a widely prescribed form of inotropic support for patients with heart failure, but infusion thereof has been associated with hypersensitivity reactions, namely eosinophilia or eosinophilic myocarditis.1e5 However, it remains unclear whether the true culprit is dobutamine per se or its excipient, sulfite.6,7 We report a case of recurrent hypereosinophilia with a skin rash that developed during dobutamine infusion. We used an in vitro flow cytometric assay to show that the hypersensitivity was attributable to sulfite.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom